• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jeena Sikho Lifecare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 76054.0
  • ISIN : INE0J5801029
554.30 -10 (-1.70%)
  • As on 13 Jul 2025 (EOD)

  • Today’s Low

    541.20

  • Today’s High

    564.00

  • Open

    564.00

  • Perv Close

    563.90

  • 52W Low

    199.50

  • 52W High

    584.00

Key Indicators

  • P/E(TTM)

    75.93

  • Mar.Cap (₹Cr.)

    6,889.99

  • Div & Yield %

    0.17

  • Book Value(₹)

    21.96

  • Debt-Equity Ratio

    -1.70

  • AGM Date

    11-Jul-2025

  • EPS

    7.30

  • P/E Ratio

    75.93

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    6,889.99

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.86

  • BV (₹)

    22.00

  • Sales( ₹ in Cr.)

    469.07

  • NP (in Cr.)

    90.73

  • NP Var(%)

    34.0

  • Div%

    55.0

  • CPS (₹)

    8.00

  • EPS (₹)

    7.30

  • Traded Value (₹ in Lakhs)

    6,889.99

  • 52 Week High

    584.00

  • 52 Week Low

    199.50

  • Price BSE

    0.0

  • Price NSE

    554.00

  • Market Capital( in Cr.)

    6,889.99

  • P/C Ratio

    69.30

  • P/E Ratio

    75.90

  • Price Vs.BV

    7.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 324.41 203.90 146.45 135.81 94.42 105.82
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 324.41 203.90 146.45 135.81 94.42 105.82
Other Income 6.44 2.28 1.49 1.07 0.76 0.06
Stock Adjustments 3.08 -1.65 -3.52 -1.28 -2.10 10.05
Total Income 333.93 204.53 144.42 135.60 93.08 115.93
EXPENDITURE :            
Raw Materials 24.84 15.48 11.94 15.01 10.15 32.73
Power and Fuel Cost 4.76 2.35 1.07 1.11 0.76 0.68
Employee Cost 65.91 43.44 33.75 30.38 21.65 14.45
Other Manufacturing Expenses 5.80 3.49 1.29 1.06 0.76 0.30
Selling and Administration Expenses 127.36 85.23 75.96 69.56 48.08 56.95
Miscellaneous Expenses 5.81 5.94 0.76 0.45 0.37 0.14
Employee Benefit Expenses 65.91 43.44 33.75 30.38 21.65 14.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 234.48 155.92 124.77 117.59 81.77 105.25
Operating Profit 99.45 48.61 19.65 18.01 11.29 10.69
Interest 0.43 0.95 1.18 1.36 1.64 1.15
Gross Profit 99.02 47.66 18.47 16.65 9.65 9.54
Depreciation 5.10 3.13 3.31 2.46 1.94 1.21
Profit Before Tax 93.92 44.53 15.16 14.19 7.71 8.33
Current Tax 23.87 11.50 3.90 3.82 1.99 2.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.84 -0.72 -0.01 0.07 0.00 0.11
Reported Net Profit 69.21 33.74 11.27 10.29 5.73 6.00
Extraordinary Items 1.34 0.40 0.59 -0.10 0.00 0.00
Adjusted Net Profit 67.87 33.34 10.68 10.39 5.73 6.00
Adjustment below Net Profit -11.05 0.00 -10.00 -0.20 0.00 0.00
P & L Balance brought forward 58.68 24.94 23.66 13.57 7.90 1.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.76 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 114.08 58.68 24.94 23.66 13.63 7.90
Dividend 2.76 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 48.00 20.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 4.80 2.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 27.84 24.43 11.15 1,015.21 572.63 599.71
Earnings Per Share(Adj)-Unit Curr 5.57 2.71 - - - -
Book Value 77.33 91.09 36.15 2,362.31 1,372.83 800.20
Book Value(Adj)-Unit Curr 15.47 10.12 - - - -

Shareholding Pattern

  • Promoter Group

    63.53%

  • Public Share Holding

    36.47%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 78,970,500 63.53 78,970,500 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 78,970,500 63.53 78,970,500 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,345,350 5.91 7,345,350 12
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 225,000 0.18 225,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,570,350 6.09 7,570,350 14
2] Non Institution
Bodies Corporate 13,860,210 11.15 13,860,210 232
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 824,280 0.66 824,280 401
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,451,245 1.17 1,451,245 259
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,529,200 6.86 8,529,200 20
Individuals holding nominal share capital up to Rs. 1 lakh 12,668,345 10.19 12,668,345 5,607
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 239,265 0.19 239,265 13
Others 85 0.00 85 1
Sub Total 37,759,880 30.38 37,759,880 6,583
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 124,300,730 100.00 124,300,730 6,603

Company Background

Jeena Sikho Lifecare LtdPharmaceuticals - Indian - Formulations

  • Jeena Sikho Lifecare Ltd
  • BSE Code : 76054.0
  • ISIN : INE0J5801029

  • Incorporation Year

    2017

  • Registered Office

    SCO 11 First Floor Kalgidhar
    Enclave Zirakpur, Mohali,
    Punjab-140604

  • Telephone

    01762-513185

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    KRA & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr ,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Jeena Sikho Lifecare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jeena Sikho 554.30 330.85 324.41 75.93 59.04
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10